Impact of clinical features of epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC) patients on osimertinib efficacy

Autor Lazzari, Chiara, Gregorc, Vanesa, Santarpia, Mariacarmela
Vydáno v J Thorac Dis (2019)

Peptide-Mediated Targeting of Cytokines to Tumor Vasculature: The NGR-hTNF Example

Autor Corti, Angelo, Curnis, Flavio, Rossoni, Gilda, Marcucci, Fabrizio, Gregorc, Vanesa
Vydáno 2013

Osimertinib in untreated epidermal growth factor receptor (EGFR)-mutated advanced non-small cell lung cancer

Autor Gregorc, Vanesa, Lazzari, Chiara, Karachaliou, Niki, Rosell, Rafael, Santarpia, Mariacarmela
Vydáno v Transl Lung Cancer Res (2018)

Mechanisms of resistance to osimertinib

Autor Lazzari, Chiara, Gregorc, Vanesa, Karachaliou, Niki, Rosell, Rafael, Santarpia, Mariacarmela
Vydáno v J Thorac Dis (2020)

Temozolomide in combination with either veliparib or placebo in patients with relapsed-sensitive or refractory small-cell lung cancer

Autor Lazzari, Chiara, Gregorc, Vanesa, Bulotta, Alessandra, Dottore, Alessia, Altavilla, Giuseppe, Santarpia, Mariacarmela
Vydáno v Transl Lung Cancer Res (2018)

Combined exosomal RNA and circulating tumor DNA for epidermal growth factor mutation detection in non-small cell lung cancer

Autor Lazzari, Chiara, Gregorc, Vanesa, Cangi, Maria Giulia, Giovannetti, Elisa, Bulotta, Alessandra, Santarpia, Mariacarmela
Vydáno v J Thorac Dis (2018)

Targeted Therapies in Early Stage NSCLC: Hype or Hope?

Autor Friedlaender, Alex, Addeo, Alfredo, Russo, Alessandro, Gregorc, Vanesa, Cortinovis, Diego, Rolfo, Christian D.
Vydáno v Int J Mol Sci (2020)

Lung cancer screening: who pays? Who receives? The European perspectives

Autor Novellis, Pierluigi, Cominesi, Silvia Raimondi, Rossetti, Francesca, Mondoni, Michele, Gregorc, Vanesa, Veronesi, Giulia
Vydáno v Transl Lung Cancer Res (2021)

Clinical Significance of Skin Toxicity due to EGFR-Targeted Therapies

Autor Giovannini, Monica, Gregorc, Vanesa, Belli, Carmen, Roca, Elisa, Lazzari, Chiara, Viganò, Maria Grazia, Serafico, Anna, Villa, Eugenio
Vydáno 2009

Historical Evolution of Second-Line Therapy in Non-Small Cell Lung Cancer

Autor Lazzari, Chiara, Bulotta, Alessandra, Ducceschi, Monika, Viganò, Maria Grazia, Brioschi, Elena, Corti, Francesca, Gianni, Luca, Gregorc, Vanesa
Vydáno v Front Med (Lausanne) (2017)

Immunohistochemical Evaluation and Clinicopathological Correlation of Mer and Axl Tyrosine Kinase TAM Receptors in Cutaneous Melanoma

Autor Pontara, Andrea, Paolino, Giovanni, Gregorc, Vanesa, Mercuri, Santo Raffaele, Bulotta, Alessandra, Bearzi, Pietro, Doglioni, Claudio, Rizzo, Nathalie
Vydáno v Dermatol Pract Concept (2020)

Spontaneous Regression of Primary Melanoma and Multiple Melanocytic Nevi in a Patient With Metastatic Melanoma

Autor Paolino, Giovanni, Rizzo, Nathalie, Pampena, Riccardo, Bearzi, Pietro, Bulotta, Alessandra, Gregorc, Vanesa, Brianti, Pina, Moliterni, Elisa, Mercuri, Santo Raffaele
Vydáno v Dermatol Pract Concept (2020)

Combination of immunotherapy with chemotherapy and radiotherapy in lung cancer: is this the beginning of the end for cancer?

Autor Lazzari, Chiara, Karachaliou, Niki, Bulotta, Alessandra, Viganó, Mariagrazia, Mirabile, Aurora, Brioschi, Elena, Santarpia, Mariacarmela, Gianni, Luca, Rosell, Rafael, Gregorc, Vanesa
Vydáno v Ther Adv Med Oncol (2018)

NGR‐hTNF and Doxorubicin as Second‐Line Treatment of Patients with Small Cell Lung Cancer

Autor Gregorc, Vanesa, Cavina, Raffaele, Novello, Sivia, Grossi, Francesco, Lazzari, Chiara, Capelletto, Enrica, Genova, Carlo, Salini, Giulia, Lambiase, Antonio, Santoro, Armando
Vydáno v Oncologist (2018)

PD-1 Inhibitors-Related Neurological Toxicities in Patients with Non-Small-Cell Lung Cancer: A Literature Review

Autor Mirabile, Aurora, Brioschi, Elena, Ducceschi, Monika, Piva, Sheila, Lazzari, Chiara, Bulotta, Alessandra, Viganò, Maria Grazia, Petrella, Giovanna, Gianni, Luca, Gregorc, Vanesa
Vydáno v Cancers (Basel) (2019)

Prognostic Role of Positron Emission Tomography and Computed Tomography Parameters in Stage I Lung Adenocarcinoma

Autor Carretta, Angelo, Bandiera, Alessandro, Muriana, Piergiorgio, Viscardi, Stefano, Ciriaco, Paola, Gajate, Ana Maria Samanes, Arrigoni, Gianluigi, Lazzari, Chiara, Gregorc, Vanesa, Negri, Giampiero
Vydáno v Radiol Oncol (2020)

Metabolism and Immune Modulation in Patients with Solid Tumors: Systematic Review of Preclinical and Clinical Evidence

Autor Mirabile, Aurora, Rivoltini, Licia, Daveri, Elena, Vernieri, Claudio, Mele, Roberto, Porcu, Luca, Lazzari, Chiara, Bulotta, Alessandra, Viganò, Maria Grazia, Cascinu, Stefano, Gregorc, Vanesa
Vydáno v Cancers (Basel) (2020)

Next Generation Sequencing in Non-Small Cell Lung Cancer: Pitfalls and Opportunities

Autor Lazzari, Chiara, Bulotta, Alessandra, Cangi, Maria Giulia, Bucci, Gabriele, Pecciarini, Lorenza, Bonfiglio, Silvia, Lorusso, Vincenza, Ippati, Stefania, Arrigoni, Gianluigi, Grassini, Greta, Doglioni, Claudio, Gregorc, Vanesa
Vydáno v Diagnostics (Basel) (2020)

History of Extensive Disease Small Cell Lung Cancer Treatment: Time to Raise the Bar? A Review of the Literature

Autor Lazzari, Chiara, Mirabile, Aurora, Bulotta, Alessandra, Viganó, Maria Grazia, Ogliari, Francesca Rita, Ippati, Stefania, Dell’Oca, Italo, Santarpia, Mariacarmela, Lorusso, Vincenza, Reck, Martin, Gregorc, Vanesa
Vydáno v Cancers (Basel) (2021)

Chemotherapy versus erlotinib as second-line treatment in patients with advanced non-small cell lung cancer and wild-type epidermal growth factor receptor: an individual patient da...

Autor Garassino, Marina Chiara, Kawaguchi, Tomoya, Gregorc, Vanesa, Rulli, Eliana, Ando, Masahiko, Marsoni, Silvia, Isa, Shun-ichi, Novello, Silvia, Farina, Gabriella, Barni, Sandro, Torri, Valter, Cinquini, Michela
Vydáno v ESMO Open (2018)